Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trials
- Resource Type
- Article
- Source
- In
Research and Practice in Thrombosis and Haemostasis March 2024 8(3) - Subject
- Language
- ISSN
- 2475-0379